Brain tDCS as a disease-modifying treatment of MS: A pilot study in a chronic EAE model

被引：0
|
作者：
Santangelo, R. [1 ]
Castoldi, V. [1 ]
Finardi, A. [1 ]
Cursi, M. [1 ]
Camaleonti, L. [1 ]
Comi, G. [1 ]
Furlan, R. [1 ]
Leocani, L. [1 ]
机构：
[1] Osped San Raffaele, Milan, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1102
引用
收藏
页码：569 / 570
页数：2
相关论文
共 50 条
  • [41] New fungal infections associated with disease-modifying treatments in MS
    Correale, Jorge
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (07) : 1004 - 1006
  • [42] DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trial
    Corboy, John R.
    Fox, Robert J.
    Cutter, Gary
    Engebretson, Eric
    Miller, Aaron
    Morgan, Charity
    Gustafson, Tarah
    Goodman, Andrew D.
    Kannan, Meena
    Sriram, Subramanian
    Xia, Zongqi
    Lynch, Sharon
    Bowen, James
    Kister, Ilya
    MULTIPLE SCLEROSIS JOURNAL, 2025, 31 (02) : 159 - 173
  • [43] AAN unveils new guidelines for MS disease-modifying therapy
    Stefan Bittner
    Frauke Zipp
    Nature Reviews Neurology, 2018, 14 : 384 - 386
  • [44] Current Disease-Modifying Treatment of Multiple Sclerosis
    Derwenskus, Joy
    MOUNT SINAI JOURNAL OF MEDICINE, 2011, 78 (02): : 161 - 175
  • [45] Disease-Modifying Treatment in Progressive Multiple Sclerosis
    John Robert Ciotti
    Anne Haney Cross
    Current Treatment Options in Neurology, 2018, 20
  • [46] Effects of MS disease-modifying therapies on responses to vaccinations: A review
    Ciotti, John Robert
    Valtcheva, Manouela V.
    Cross, Anne Haney
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 45
  • [47] DISCOntinuation of disease-modifying therapies in MS (DISCOMS) extension - Study design and baseline demographics
    Engebretson, E.
    Cutter, G.
    Fox, R.
    Kister, I.
    Miller, A.
    Morgan, C.
    Seale, R.
    Corboy, J.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 628 - 629
  • [48] Disease-modifying interactions between chronic kidney disease and osteoarthritis: a new comorbid mouse model
    Julovi, Sohel M.
    Dao, Aiken
    Trinh, Katie
    O'Donohue, Alexandra K.
    Shu, Cindy
    Smith, Susan
    Shingde, Meena
    Schindeler, Aaron
    Rogers, Natasha M.
    Little, Christopher B.
    RMD OPEN, 2023, 9 (03):
  • [49] Advances in Disease-Modifying Therapeutics for Chronic Neuromuscular Disorders
    Davalos, Long
    Kushlaf, Hani
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2024,
  • [50] Theophylline in chronic asthma - Evidence for disease-modifying properties
    Chung, KF
    CLINICAL AND EXPERIMENTAL ALLERGY, 1996, 26 : 22 - 27
12345